Truist Financial Raises Astrana Health (NASDAQ:ASTH) Price Target to $47.00

Astrana Health (NASDAQ:ASTH) had its price objective boosted by analysts at Truist Financial from $38.00 to $47.00 in a research note issued to investors on Thursday, Marketbeat.com reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s target price would suggest a potential upside of 22.84% from the stock’s current price.

A number of other research analysts have also commented on the stock. Weiss Ratings upgraded shares of Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. TD Cowen lifted their price objective on shares of Astrana Health from $35.00 to $45.00 and gave the company a “buy” rating in a research note on Tuesday. Needham & Company LLC lifted their price objective on shares of Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Barclays lifted their price objective on shares of Astrana Health from $26.00 to $37.00 and gave the company an “equal weight” rating in a research note on Monday. Finally, Robert W. Baird set a $45.00 price objective on shares of Astrana Health in a research note on Friday, May 8th. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $43.14.

Astrana Health Price Performance

Shares of NASDAQ:ASTH opened at $38.26 on Thursday. The company’s fifty day moving average price is $29.30 and its 200 day moving average price is $25.96. Astrana Health has a 12 month low of $18.08 and a 12 month high of $39.93. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.40. The firm has a market capitalization of $2.13 billion, a P/E ratio of 62.72 and a beta of 0.98.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The firm had revenue of $965.10 million for the quarter, compared to analyst estimates of $949.21 million. During the same period last year, the business earned $0.42 EPS. Astrana Health’s revenue for the quarter was up 55.6% compared to the same quarter last year. As a group, sell-side analysts predict that Astrana Health will post 1.25 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. Signaturefd LLC boosted its holdings in Astrana Health by 57.9% during the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after buying an additional 388 shares in the last quarter. Amalgamated Bank lifted its holdings in shares of Astrana Health by 3.4% in the third quarter. Amalgamated Bank now owns 12,325 shares of the company’s stock valued at $349,000 after purchasing an additional 409 shares in the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of Astrana Health by 1.5% in the third quarter. Thrivent Financial for Lutherans now owns 30,977 shares of the company’s stock valued at $878,000 after purchasing an additional 455 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Astrana Health by 0.3% in the third quarter. Principal Financial Group Inc. now owns 222,985 shares of the company’s stock valued at $6,322,000 after purchasing an additional 611 shares in the last quarter. Finally, Savant Capital LLC lifted its holdings in shares of Astrana Health by 2.2% in the third quarter. Savant Capital LLC now owns 30,713 shares of the company’s stock valued at $871,000 after purchasing an additional 649 shares in the last quarter. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.